Article Details

Morgan Stanley Trims Neurocrine Biosciences (NASDAQ:NBIX) Target Price to $121.00

Retrieved on: 2020-12-16 18:10:59

Tags for this article:

Click the tags to see associated articles and topics

Morgan Stanley Trims Neurocrine Biosciences (NASDAQ:NBIX) Target Price to $121.00. View article details on hiswai:

Excerpt

<b>Morgan Stanley's</b> price objective indicates a potential upside of 24.38% from the stock's previous close. Other research analysts have also recently ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up